Autonom-inc – Researchers in China and the US developed a vaccine that is effective in dealing with the corona virus. If successful, the first test is done in three months. The vaccine will be available at the earliest this year.
The first step is to obtain an effective vaccine against the coronavirus novel (2019-nCoV). Researchers at the Centers for Disease Control and Prevention (CDC) in China have identified viruses and shared data with the world quickly.
Xu Wenbo, head of the CDC, told local reporters that the researchers quickly isolated the virus and analyzed its genetic makeup.
Both are important first steps to understanding the virus and how to stop it.
This is the first time in human history where scientists have identified a new virus that can spread from animals to humans, sequenced the virus genetically, copied it in the laboratory, and shared information so quickly.
Vaccine development begins
This means that researchers in China have been able to start working on vaccines. Other researchers in the US, Australia and other countries are also looking for an appropriate vaccine.
In the US, the National Institute of Health has formed a vaccine development group, with Anthony S. Fauci as its leader, to coordinate further strategies.
In the Journal of the American Medical Association (FAMA), Fauci said that two vaccines developed for another type of corona virus, known as SARS and MERS, could be a good basis for developing new vaccines.
By using what is called a “vaccine platform,” the researchers took a relatively harmless virus (such as the common cold) and added corona virus elements to it to trigger a reaction from the immune system.
One thing that makes developing vaccines against the corona virus very difficult, is the ability of the virus to adapt.
Meanwhile in Australia, a team led by Keith Chappell at the University of Queensland also developed the vaccine.
The Chappell Team is part of a group calling itself the Coalition for Innovation Epidemic Preparedness (CEPI). Together, they aim to develop vaccines using “molecular brace.”
The idea is to make the virus at the earliest stage appear as a stable virus in the body. That will allow the human immune system to be able to attack the virus before the virus enters the body’s cells. When a virus enters a cell, it becomes very dangerous. Replication and distribution are getting stronger.
US researchers hope to begin testing vaccines in humans within three months. If all goes well, the fastest vaccine can be marketed in the middle of 2020. That will also be a record in the history of vaccine development. During SARS, it takes 20 months after the viral genome is successfully sequenced.